1 Ocak 2017 Dergi makalesi Açık Erişim

Erturk, Zeliha; Buber, Esra; Ozen, Haluk; Celikbicak, Omur; Salih, Bekir; Acan, N. Leyla

MARC21 XML

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">user-tubitak-destekli-proje-yayinlari</subfield>
    <subfield code="o">oai:zenodo.org:47033</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Objective: Immunotherapy with intravesical Bacillus Calmette-Guerin (BCG) application is a gold standard treatment for high risk non-muscle invasive bladder cancer (NMIBC), despite its local and systemic side effects. We aimed to develop less toxic and more powerful therapeutic agents for the treatment of bladder cancer than live strain.</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">article</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="a">Creative Commons Attribution</subfield>
    <subfield code="u">http://www.opendefinition.org/licenses/cc-by</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Erturk, Zeliha</subfield>
    <subfield code="u">Hacettepe Univ, Fac Med, Dept Med Biochem, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="z">md5:9ee20076cf9bc2d697f350d2c286b2c0</subfield>
    <subfield code="s">684265</subfield>
    <subfield code="u">https://aperta.ulakbim.gov.trrecord/47033/files/10-4274-uob-905.pdf</subfield>
  </datafield>
  <controlfield tag="005">20210315215712.0</controlfield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-01-01</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.4274/uob.905</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="4">
    <subfield code="v">16</subfield>
    <subfield code="p">UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY</subfield>
    <subfield code="c">70-76</subfield>
    <subfield code="n">3</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Buber, Esra</subfield>
    <subfield code="u">Hacettepe Univ, Fac Med, Dept Med Biochem, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Ozen, Haluk</subfield>
    <subfield code="u">Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Celikbicak, Omur</subfield>
    <subfield code="u">Hacettepe Univ, Fac Sci, Dept Chem, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Salih, Bekir</subfield>
    <subfield code="u">Hacettepe Univ, Fac Sci, Dept Chem, Ankara, Turkey</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Acan, N. Leyla</subfield>
    <subfield code="u">Hacettepe Univ, Fac Med, Dept Med Biochem, Ankara, Turkey</subfield>
  </datafield>
  <controlfield tag="001">47033</controlfield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-tubitak-destekli-proje-yayinlari</subfield>
  </datafield>
</record>